A new £4.3m government funding scheme is set to boost the manufacturing of medicines and treatments, including those used to treat blood cancers and inherited disorders.
Companies in Northumberland, Oxford and London will adopt new digital technologies, such as artificial intelligence, to support the manufacture of next-generation medicines and treatments.
The funding aims to create more efficient and innovative methods for manufacturing medicines. According to the government the scheme aims to set the UK apart as “a leader” with greater capacity for manufacture of safe, affordable and effective therapies.
Life sciences minister Lord Henley said: “New technology can help us live longer, healthier lives and the new projects announced today will improve the speed and accuracy with which medicines get to the people that need them.
“Advances in technology can help us address the challenges that an ageing society presents and we are backing the technologies of tomorrow in our modern Industrial Strategy, with the biggest increase in public research and development investment in UK history.”